LEADER 00000nam  2200000Ia 4500 
001    432326260    
003    OCoLC 
005    20090821140023.0 
006    m        d f       
007    cr an||||||||| 
008    090821s2002    mdu     s    f000 0 eng d 
040    GPO|cGPO|dMvI 
074    0499-T (online) 
086 0  HE 20.4702:IN 3/2 
245 00 Guidance for industry|h[electronic resource] :
       |binformation program on clinical trials for serious or 
       life-threatening diseases and conditions. 
246 30 Information program on clinical trials for serious or life
       -threatening diseases and conditions. 
260    Rockville, MD :|bU.S. Dept. of Health and Human Services, 
       Food and Drug Administration, Center for  Drug Evaluation 
       and Research,|c[2002] 
300    1 online resource (9 p.) :|bdigital, PDF file. 
500    "Center for Biologics Evaluation and Research (CBER)." 
500    "Procedural." 
500    "March 2002." 
650  0 Clinical trials|xGovernment policy|zUnited States. 
710 2  Center for Drug Evaluation and Research (U.S.) 
710 2  Center for Biologics Evaluation and Research (U.S.) 
856 40 |uhttp://purl.access.gpo.gov/GPO/LPS116359 
LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE